## BA: The Boeing Company - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%); PEG 6.53 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($208.25)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 1)

**1. Airbus Vs. Boeing: Who Finished 2025 With More Orders?**
- Source: Simple Flying | 20251231T000804 | Neutral | Relevance: 100%
- In 2025, Boeing secured 985 commercial airliner orders, surpassing Airbus's 802. While Airbus led in narrowbody sales with 544 orders, Boeing dominated the widebody market, particularly with its 787 Dreamliner and 777X families, which significantly outpaced Airbus's A330neo and A350 sales. The article details the performance of various aircraft models for both manufacturers and attributes some of Boeing's success to political deal-making.

**2. Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year.**
- Source: Barron's | 20251230T220740 | Bullish | Relevance: 100%
- Boeing is experiencing a strong recovery and its stock could see a 25% gain in the next 12 months, according to analysts at Tigress Financial Partners. The aerospace-and-defense company is projected to deliver nearly 700 jets in 2026. This positive outlook suggests continued growth for Boeing.

**3. Boeing awarded $10.6B for Israeli Jets and B-52 upgrades**
- Source: Lynnwood Times | 20251230T165229 | Bullish | Relevance: 100%
- Boeing has secured two significant contracts from the United States Air Force totaling over $10 billion. These contracts involve supplying up to 50 F-15IA fighter jets to Israel and initiating a $2.04 billion program to upgrade the engines of the B-52 bomber fleet, extending their operational life. These deals come as Boeing's Defense, Space & Security division reports strong growth.

**4. Boeing awarded $8.6B contract to build jets for Israel**
- Source: NewsNation | 20251230T160741 | Bullish | Relevance: 100%
- Boeing has secured an $8.6 billion contract to produce 25 new F-15A aircraft for the Israeli Air Force, with an option for 25 more. This agreement is part of the F-15 Israel program and follows discussions between President Donald Trump and Israeli Prime Minister Benjamin Netanyahu regarding a Gaza ceasefire. The work will be carried out at Boeing's St. Louis location, with an expected completion date of December 31, 2035.

**5. Pentagon awards Boeing $8.6B contract for F-15 jets for Israel**
- Source: Anadolu AjansÄ± | 20251230T043933 | Bullish | Relevance: 100%
- The Pentagon has awarded Boeing an $8.6 billion contract for the F-15 Israel Program, providing for the design, integration, test, production, and delivery of 25 new F-15IA aircraft for the Israeli Air Force, with an option for an additional 25. The work will be performed in Missouri and is expected to be completed by December 31, 2035. This announcement followed a meeting between US President Donald Trump and Israeli Prime Minister Benjamin Netanyahu.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | JP Morgan | $245 | $240 | +2% |
| 2025-12-12 | Citigroup | $265 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | JP Morgan | main | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.10M) |
| Sells | 7 ($0.75M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (+1.1%)
- Blackrock Inc.: 6.8% (+2.7%)
- FMR, LLC: 5.8% (+16.1%)
- State Street Corpora: 4.6% (+0.3%)
- Newport Trust Compan: 3.8% (+2.5%)

### Key Risks

1. Valuation stretched: PEG 6.5x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 6.53 signals overvaluation risk, limited margin of safety. Institutional flow bearish (2 selling vs 8 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $170.0B |
| Beta | 1.18 |
| 52W Range | $128.88 - $242.69 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.53 |
| Forward P/E | 92.8 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 2.4% to 1.4% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.11), confirming momentum. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.40% (CS: 91) | Neutral |
| RSI_14 | 65.5 | Neutral |
| MACD Histogram | 1.11 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 1.058x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $217.13
- **Stop Loss:** $208.25 (4.1% risk)
- **Target:** $226.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 135
- **Position Value:** $29,312.55
- **Portfolio %:** 29.31%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-01-28 (Est: $-0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-2.38 | $-7.47 | -214.4% |
| 2025Q2 | $-1.27 | $-1.24 | +2.4% |
| 2025Q1 | $-1.30 | $-0.49 | +62.4% |
| 2024Q4 | $-3.78 | $-5.90 | -56.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*